Rooperol tetraacetate decreases cytokine mRNA levels and binding capacity of transcription factors in U937 cells. by Guzdek, A et al.
Rooperol tetraacetate decreases
cytokine mRNA levels and binding
capacity of transcription factors in
U937 cells
A. Guzdek,
1 H. Rokita,
1 J. Cichy,
1 A. C. Allison
2
and  A. Koj
1,CA
1Institute of Molecular Biology, Jagiellonian
University, Al. Mickiewicza 3, 31–120 Krak´ ow,
Poland; 
2DAWA Inc., Belmont, CA 94002, USA
CACorresponding author
Fax: (+48) 12 6336907
Email: KOJ@mol.uj.edu.pl
WE have previously described inhibition of the syn-
thesis of three acute-phase inflammatory cytokines in
human  and  rat  macrophages  by  acetate  esters  of
rooperol, a dicatechol of plant origin. Analysing the
mechanism of  anticytokine activity of  rooperol,  we
compared levels of TNFa , IL-1b and IL-6 mRNAs in the
human promonocytic U937 cell line pretreated with
phorbol myristate acetate (PMA) and incubated with
rooperol tetraacetate (RTA) alone or in combination
with  LPS  (500 ng/ml).  It  was  found  that  10 m M  RTA
decreased the levels of cytokine mRNAs both in the
presence and absence of LPS, suggesting pretransla-
tional  inhibition  of  cytokine  synthesis.  Electropho-
retic mobility shift analysis (EMSA) showed that RTA
may influence cytokine mRNA expression by decreas-
ing the binding activity of transcription factors NF-k B
and AP-1.
Key  words:  U937  cells,  Cytokine  mRNA, Transcription
factors, Rooperol tetraacetate
Introduction
Macrophages,  ubiquitous  in  the  body,  have  the
potential  to  produce  several  cytokines  involved  in
inflammation,  such  as  TNFa ,  IL-1b and  IL-6.1–5
Induced synthesis of these cytokines involves multi-
ple cell signalling pathways and can be regulated at
the level of gene transcription, mRNA stability and
translation,  or  cytokine  precursor  processing  and
secretion.4,5 Overproduction of cytokines is believed
to play a role in the pathogenesis of a wide range of
disorders, such as septic shock, rheumatoid arthritis
and asthma.6–9 Compounds which suppress cytokine
production may have beneficial effects in the treat-
ment of such diseases. The list of anti-inflammatory
drugs affecting cytokine production is growing stead-
ily and involves glucocorticoids, some antioxidants,6
bicyclic  imidazoles,10 piperazine  derivatives,11 teni-
dap7,8 and many others. We have recently described
inhibition of the TNFa , IL-1b and IL-6 (at the protein
level) in human and rat alveolar macrophages, human
blood monocytes and human promonocytic cell line
U937 by a plant dicatechol, rooperol, and its acetate
esters.12 Rooperol  derived  from  the  plant  Hypoxis
rooperi is a potent inhibitor of 5-lipoxygenase, but in
concentrations up to 10m M has  no activity against
either isoform of cyclooxygenase.13This suggests that
the drug might be therapeutically useful in disorders
when  it  is  desirable  to  inhibit  the  production  of
leukotrienes but not prostaglandins, such as asthma
and inflammatory bowel disease. Evidence is accumu-
lating that pro-inflammatory cytokines also contribute
to  the  pathogenesis  of  these  as  well  as  other
inflammatory disorders, so that it would be desirable
to inhibit their production as well. Although rooperol
exhibit antioxidative properties,13 and suppresses NO
production by rat macrophages12 and murine endo-
thelial  cells,14 (overproduction of  NO  by inducible
NO synthase may contribute to the pathogenesis of
asthma9), the mechanism of its anticytokine activity
requires  elucidation. The study  now  reported is an
analysis of  the  mechanism  by which  rooperol may
suppress  the  production  of  pro-inflammatory  cyto-
kines. We describe the effect of rooperol tetraacetate
on the TNFa , IL-1b and IL-6 mRNAs, as well as DNA-
binding activity of two transcription factors in U937
cells  exposed  to  rooperol  in  the  presence  and
absence of bacterial endotoxin.
Materials and Methods
Reagents
RPMI  medium,  fetal  bovine  serum  (FBS)  and  anti-
biotics–antimycotics were purchased from Gibco Life
Technologies Inc. (Grand Island, NY); [a -32P]dCTP and
[g -32P]ATP  were  obtained  from  Amersham  Inter-
national  (Amersham,  UK).  Oligonucleotide  probes
were synthesized by Dr. A. Okruszek, Macromolecular
Research Centre, Polish Academy of Sciences, ´ Lod´ z,
Poland. All other reagents were from Sigma (St Louis,
MO, USA). Endotoxin (LPS, lipopolysaccharide from
Escherichia  coli 026:B6,  Sigma,  St  Louis, MO) was
dissolved in sterile phosphate-buffered saline (PBS) at
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(39 ,49 -dihydroxyphenyl) pent-4-en-1-yne) tetraacetate
(RTA)  was  dissolved  in  DMSO  as  described  pre-
viously12 to obtain a stock solution (100 mM), and was
further diluted in 10%  bovine serum albumin in PBS.
Cell culture
U937  cells  were  grown  at  37°C  in  75-cm2 flasks
containing  RPMI  supplemented  with  8%   FBS  and
antibiotics under a humidified atmosphere of 95% air
and  5%  CO2.  Every  third  day  the  medium  was
doubled, and every sixth day cells were centrifuged
and  suspended  (1:4)  in  the  fresh  medium.  The
experiments were carried out on U937 cells differ-
entiated into a macrophage-like cells in the presence
of  PMA  at  a  concentration  of  34ng/ml  for  48h.
During  that  period  viable  and  differentiated  cells
adhered to the culture plates. Unattached cells were
discarded and tested factors (in RPMI with 2% FBS)
added after additional 24h culturing of the adherent
cells  without  PMA.  Cells  were  cultured  in  12-well
plates  (Costar)  (106 cells  per  well)  for  cytokine
estimation  by  ELISA,  in  90mm  Petri  dishes  (7  3
106cells per dish) for mRNA isolation and in 60mm
Petri dishes (3 3 106 cells per dish) for isolation of
nuclear proteins.
Cytokine assay
In order to avoid discrepancies  related to cytokine
secretion, total (medium + cells) TNFa , IL-1b and IL-6
proteins were determined using commercially avail-
able ELISA kits (Genzyme). After 24h of culture with
the tested factors, U937 cells were scraped from the
wells  directly  into the  medium,  subjected to  three
cycles  of  freezing  and  thawing,  and  centrifuged
(10000g for 3min) before cytokine determination.
Isolation of RNA and Northern blot analysis
Total  U937  RNA  was  extracted  using  the  phenol
extraction method and LiCl precipitation as described
by  Rose-John  et  al.15 from  the  cells  treated  with
10m M RTA for 1h followed by 2 or 18h incubation
with  500ng/ml  LPS  up  to  the  moment  of  RNA
extraction.  RNA  samples  (5m g)  were  separated  by
electrophoresis in 1% agarose gel under denaturing
conditions.
16 RNA was then transferred to Hybond-N
membranes (Amersham, Arlington, IL) according to
the  manufacturer’s  instructions.  Hybridization  with
32P-labelled probes was performed overnight at 65°C
in a mixture containing 1.0 M NaCl, 1% SDS and 10%
dextran  sulphate.  Specific  mRNAs  were  detected
using the following probes : 1.1-kb PstI-PstI restric-
tion fragment of human TNFa cDNA (ATCC, Rock-
ville, MA), 1.2-kb EcoRI-HindIII fragment of human IL-
6 cDNA (a generous gift of Dr T . Kishimoto), pGEMI
containing  a  570bp  SstI-PvuII  cDNA  fragment  of
human IL-1b (kindly provided by ImmunexTM, Seattle,
WA), a cDNA probe specific for the human  glycer-
aldehyde  3-phosphate  dehydrogenase  (GAPDH)
(ATCC, GenBank/EMBL: M17851), and a 1.5-kb PstI-
PstI  fragment  of  the  pSP64  coding  for  rat  b -actin
(kindly  provided  by  Dr  J.  Sipe,  Boston,  USA). The
probes  were  labelled with Megaprime Labeling Kit
(Amersham). As the reference, 18 S and 28 S rRNA
were visualized in UV light  after ethidium bromide
staining, or 18 S rRNA determined by hybridization
with the EcoRI-SalI fragment of the plasmid contain-
ing human 18 S rRNA cDNA (kindly provided by N.
Bhownick, Athens, GA). Non-specifically bound radio-
activity was removed by washing and the blots were
subjected to autoradiography at -70o C using intensify-
ing screens. The relative intensity of the bands was
evaluated by densitometry using a computer imaging
(MCID) system (Imaging Research Inc., Canada).
Nuclear protein extraction
Nuclear proteins were obtained by the mini extrac-
tion  procedure  described  by  Suzuki  et  al.17 PMA-
primed U937 cells were cultured for 1h with 10m M
RTA followed by exposure to 500 ng/ml of LPS up to
the moment of cell collection. Cells were collected
with a rubber policeman, washed twice with cold PBS
and  centrifuged  for  5min  at  400  3 g. The  cells,
suspended  in  buffer  containing  10mM  HEPES  (pH
7.8),  10mM  KCl,  2mM  MgCl2,  1mM  DTT ,  0.1mM
EDTA, and 0.1mM PMSF , were incubated on ice for
15min. Nonidet P-40 was added and samples were
centrifuged for 30s at 14000 r.p.m. Pelleted nuclei
were resuspended in buffer containing 50 mM HEPES,
50mM KCl, 300mM NaCl, 0.1mM EDTA, 1mM DTT
and  0.1mM  PMSF ,  centrifuged  for  5min  at  14000
r.p.m. at 4°C and the supernatant was frozen in 10%
glycerol. The protein concentration was determined
by Lowry’s method.
EMSA
The following double-stranded oligonucleotides were
used for DNA electrophoretic mobility shift assay: the
oligonucleotide that contained two binding sites for
NF-k B  from  c-myc  oncogene  corresponding  tobp
–1101–1081  (5’-AAGTCCGGGTTTTCCCCAACC-3’)18
and  AP-1  oligonucleotide:  5’-TCGACTAGTATGAGT -
CAGCCG-3’.19 These  oligonucleotide  probes  were
either  end-labelled  with  [g -32P]ATP  and  T4  poly-
nucleotide  kinase  (NF-k B)  or  labelled  with
[a -32P]dCTP  and Klenow polymerase (AP-1)  (Mega-
prime  Labeling  Kit).  For  gel  shift  analysis  5m g  of
nuclear  proteins  were  incubated  with  0.5ng
(c.105cpm)  of  labelled  oligonucleotides.  As  com-
petitors, a 100-fold excess of the unlabeled oligonu-
cleotide was added to the binding reaction.
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Rooperol tetraacetate inhibition of cytokine
mRNAs in PMA-primed U937 cells cultured in
the presence and absence of LPS
We  found  previously  that  LPS-induced  synthesis  of
TNFa , IL-1b and IL-6 proteins was inhibited in human
and rat  alveolar  macrophages,  human  blood mono-
cytes/macrophages and U937 cells exposed to roo-
perol and its acetate esters.12This has been confirmed
and  extended  by  the  data  shown  in Table  1. The
inhibitory effect of rooperol is less pronounced than
in blood monocytes12 because ‘control’ U937 cells are
in fact significantly stimulated by PMA.
Since cytokine gene expression is often regulated at
the  pretranslational  stages1,4,5 we  determined  the
levels of specific mRNAs in U937 cells primed with
PMA and stimulated with LPS. To compare early and
late responses, measurements of the cytokine mRNAs
were carried out at 2 and 18h after exposure to LPS.
Figure  1A  shows  that  control  cells  express TNFa
mRNA,  due  to  stimulation  with  PMA,  whereas
unprimed  and  unattached  cells  do  not  produce
cytokines even after stimulation with LPS (Fig. 1B and
Ref. 20). As expected, stimulation with LPS increased
the abundance of TNF mRNA, especially after 2h. We
also  found  that  pretreatment  of  cells  with  RTA
decreased levels of TNFa mRNA both in control and
LPS-stimulated cells (Fig. 1A and B). Similar pictures
were  obtained  in  three  consecutive  experiments.
Exposure  of  U937  cells  to  RTA also decreased the
amounts  of  IL-1b and  IL-6  mRNAs,  but  the  effects
were more pronounced after 18h culture with LPS
or/and RTA (Figs 2 and 3). Six independent experi-
ments were carried out and Figs 2 and 3 show typical
results. The inhibitory activity of RTA appears to be
rather specific for cytokine mRNAs since the amount
of 18 S RNA was unaffected both in the presence and
absence of LPS. Moreover, RTA at 10 m M concentra-
tion had no significant effect  on the  expression of
Inhibition of cytokine synthesis in U937 cells
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Table 1. Total concentrations (supernatants + cell lysates)  of
cytokines (ng/ml) in U937 cells after 24h of culture with RTA
(10m M) or LPS (500ng/ml), or RTA and LPS. All cells were
primed with PMA as described in Materials and Methods.
Mean  of  four  to  five  experiments;  ±SD.  The  statistical
differences were evaluated by paired Student’s t-test in pairs:
control vs RTA*, or control vs LPS**, or LPS vs LPS+RTA***.
NS, not significant (P › 0.05)
TNFa IL-1b IL-6
Control 12.11 ± 2.49 17.10 ± 5.38 7.57 ± 3.00
P < 0.05* P < 0.05* P < 0.01*
RTA 9.23 ± 2.72 13.87 ± 5.54 5.37 ± 1.35
LPS 15.75 ± 3.92 23.24 ± 5.42 14.53 ± 5.63
P < 0.01** P < 0.02** P < 0.02**
LPS + RTA 11.73 ± 1.72 18.75 ± 7.60 10.57 ± 3.46
P < 0.02*** NS P < 0.05***
FIG. 1. (A and B) Effect of RTA (10m M) and/or LPS (500ng/ml) on relative TNFa mRNA abundance in unprimed* (B, lane 3) U937
cells or in the cells primed for 48h with PMA (34 ng/ml) and exposed for 1h to RTA and for the next 2h to LPS. For comparison
blots were rehybridized with a probe for 18 S RNA (A) or UV picture of 18S and 28S rRNA in the ethidium bromide-stained gel
is shown (B). For further detail see Materials and Methods. In order to account for differences in RNA load of the gel the ratios
of densitometric scans of TNF-a mRNA to 18 S rRNA are reported (A).b -actin (a typical structural protein of the cell) and
GAPDH (one of the glycolytic pathway enzymes) (Fig.
4).  These  results  suggest  that  RTA  inhibits  the
synthesis of inflammatory cytokines at the transcrip-
tional  level. As  shown  recently  by several  authors,
translation of cytokine mRNA requires an additional
signal provided by stress-responsive kinases and thus
in certain cases a dissociation of transcription from
translation  may  occur.4,21 Our  results  presented  in
Table 1  indicate  that  changes in the  total  cytokine
contents (cell + media) elicited by LPS and RTA in
U937  cells  roughly  correspond  to  changes  in  the
amount of the specific mRNAs (Figs 1–3), which is
consistent  with  a  pretranslational  site  of  action  of
RTA.
Inhibition of binding activity of transcription
factors NF-k B and AP-1 by RTA in PMA-primed
U937 cells cultured in the presence and
absence of LPS
Cytokine  gene  promoters  contain  multiple  regula-
tory  elements  recognized  by  several  transcription
factors,  the  most  important  being  NF-k B, AP-1  and
C/EBP .4,5,22 It is known that in U937 cells both PMA
and  LPS  activate  NF-k B.23–25 Figure  5A shows  that
RTA decreased NF-k B binding activity in PMA-primed
(control)  and  LPS-stimulated  U937  cells  30  min.
following exposure to LPS. At shorter (15min) (Fig.
5B) or longer than 4h incubation times the effect of
RTA  was  less  pronounced  (data  not  shown). The
inhibitory effect of RTA was comparable in control
(PMA-primed)  and  LPS-stimulated  cells  (Fig.  5A).
When  nuclear  extracts  from  U937  cells  were  ana-
lysed  by  EMSA  (three  independent  experiments)
with  the AP-1  probe  inhibition  of  binding  by  RTA
was observed after 30min and after 1h exposure to
LPS (Fig. 6).
Discussion
The  U937  cell  line,  primed  toward  macrophage
differentiation  with  PMA,  is  a  useful  model  for
studying the regulation of cytokine synthesis.17,24,25
Although PMA affects protein kinase C and induces
synthesis of cytokines (high ‘control’ values), thereby
reducing the relative response to LPS, the U937 cells
represent  a  uniform  population  that  can  be  easily
cultured in amounts sufficient for analysis of RNA and
nuclear proteins. Using this model we demonstrated
that  RTA  in  10m M  concentration,  which  does  not
A. Guzdek et al.
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FIG. 2. The effect of RTA (10m M) and/or LPS (500ng/ml) on IL-
1b mRNA abundance in PMA-primed U937 cells after 18h
incubation  with  LPS  and/or  with  RTA  (cf.  Fig.  1).  For
comparison, the UV picture of 18 S and 28 S rRNA in the
ethidium bromide-stained gel is shown. Densitometric scans
of IL-1 mRNA are expressed in arbitrary units.
FIG. 3. Effect of RTA (10m M) and/or LPS (500ng/ml) on IL-6
mRNA  abundance  in  PMA-primed  U937  cells  after  18h
incubation  (cf.  Fig.  2).  For  comparison,  the  hybridization
pattern of 18 S rRNA is shown. The ratios of densitometric
scans of IL-6 mRNA to18 S rRNA are reported.
FIG. 4. Abundance of GAPDH mRNA and b -actin mRNA in
PMA-primed U937 cells cultured for 18h with RTA (10m M)
and/or LPS (500ng/ml).show detectable cytotoxic effects such as inhibition
of  total  protein  synthesis  or  leakage  of  lactate
dehydrogenase,12 decreases  abundance  of  mRNAs
coding for TNFa , IL-1b and IL-6 both in control (PMA-
primed)  and  LPS-stimulated  U937  cells  (Figs  1–3).
From comparison of scanning values it is evident that
the ‘inhibitory index’ (control vs. RTA, and LPS vs.
LPS+RTA) is very similar suggesting that RTA acts on
both  PMA-induced  and  LPS-induced  expression  of
cytokine genes. This may indicate a common target of
RTA on the intracellular signalling pathway but the
problem requires further studies.
On  the  other  hand,  mRNAs  coding  for  other
cellular proteins (GAPDH, b -actin) were not detect-
ably affected by RTA. Thus, it can be concluded that
RTA inhibits synthesis of the inflammatory cytokines
at  the  transcriptional  level,  in  contrast  to  other
inhibitors such as bicyclic imidazoles22 or piperazine
derivatives11 which affect translation stages, or teni-
dap,  which  acts  indirectly  by  inhibiting  the
cyclooxygenase  pathway.26 The  observed  decreases
in the amounts of cytokine mRNAs in the presence
of RTA could result from corresponding changes in
transcription  rates  or  mRNA  stability.  Cytokine
mRNAs  contain  adenylate/uridylate-rich  elements
which are held responsible for the short half life of
their messages.27 To exclude the possibility that RTA
enhances  the  rate  of  cytokine  mRNA  degradation
additional  experiments  with  actinomycin  D  are
required.
On the other hand, the results of our experiments
point to the interaction of rooperol with transcription
factors,  known  to  be  required  for  cytokine  gene
transcription: NF-k B and AP-1. The activation of NF-k B
Inhibition of cytokine synthesis in U937 cells
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FIG. 5. (A and B) Inhibition by RTA of NF-k B binding to DNA sequences. Electrophoretic mobility shift assay of nuclear extracts
isolated from (A) control, RTA- (10m M), LPS- (500ng/ml) or RTA + LPS-treated U937 cells primed with PMA; (B) LPS- (500ng/ml)
or LPS+RTA (10m M)- treated U937 cells primed with PMA. Cells were incubated for 1h with RTA, followed by LPS addition (A)
for 30min or (B) for 15min, lanes 1,2; 45min, lanes 3,4; and 90min, lanes 5,6. In lane 7 competitor (unlabelled oligo DNA) was
run. The nuclear extracts were isolated and processed as described in Materials and Methods. Densitometric scans (A) are
expressed in arbitrary units.
FIG.  6.    Inhibition  of  AP-1  binding  to  DNA  sequences
following 60min RTA treatment or/and 60min exposure to
LPS. Electrophoretic mobility shift assay of nuclear extracts
isolated  from  control,  RTA-  (10m M),  LPS-  (500ng/ml)  or
LPS+RTA- treated U937 cells primed with PMA. Cells were
incubated  for 60min  with RTA, followed by an  additional
60min with LPS and then nuclear extracts were isolated and
processed as described in Materials and Methods. Densito-
metric scans are expressed in arbitrary units.involves an oxidation step with possible involvement
of  reactive  oxygen  species17,28 and  several  anti-
oxidants showing anti-inflammatory properties act at
this stage.6,28 As shown by van der Merwe et al.13
rooperol belongs to the group of biologically active
antioxidants,  and  thus  by  interfering  with  NF-k B
activation  may  inhibit  synthesis  of  inflammatory
cytokines. Redox regulation of the AP-1 transcription
factor complex is also well documented in both U937
and HeLa cells24,29 and may explain the RTA-elicited
reduction  of AP-1  binding  observed  in  our  experi-
ments (Fig. 6). Since EMSA showed only a transient
decrease  in  the  binding  capacity  of  NF-k B  other
possible sites of anticytokine action of RTA may be
identified in future.
We  can  conclude,  however,  that  RTA  influences
abundance of mRNAs coding for TNFa , IL-1b and IL-6
in human macrophage-like cells and affects binding of
transcription  factors  implicated  in  cytokine  gene
expression. This provides a better understanding of
the activity of RTA as potential anti-inflammatory and
anticytokine drug.
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